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Figure S1.   
 
Cell cycle distributions for breast cancer (MDA-MB-231) cells obtained using ImageXpressultra 
system following exposure to various metallocorroles (30 μM of 1-Ga, 1-Fe, 1-Mn, 1-Al, 2-Mn, 
and 3-Mn). 
 
 
Figure S2.   
 
Cell cycle distributions for ovarian cancer (OVCAR-3) cells obtained using ImageXpressultra 
system following exposure to various metallocorroles (30 μM of 1-Ga, 1-Fe, 1-Mn, 1-Al, 2-Mn, 
and 3-Mn). 
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Ovarian cancer (OVCAR-3) cells 
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